Jöns Lundmark

801 total citations
17 papers, 591 citations indexed

About

Jöns Lundmark is a scholar working on Psychiatry and Mental health, Pharmacology and Pharmacology. According to data from OpenAlex, Jöns Lundmark has authored 17 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 8 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Jöns Lundmark's work include Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Electroconvulsive Therapy Studies (4 papers). Jöns Lundmark is often cited by papers focused on Treatment of Major Depression (8 papers), Schizophrenia research and treatment (5 papers) and Electroconvulsive Therapy Studies (4 papers). Jöns Lundmark collaborates with scholars based in Sweden, Denmark and Italy. Jöns Lundmark's co-authors include Margareta Reis, Finn Bengtsson, Jan Wålinder, Marja­‐Liisa Dahl, Conny Nordin, Elisabeth Skogh, F. Bengtsson, Henrik Björk, Björn Carlsson and Björn Mårtensson and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and The Journal of Clinical Psychiatry.

In The Last Decade

Jöns Lundmark

16 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jöns Lundmark Sweden 11 277 271 143 95 71 17 591
Roland Berecz Hungary 19 381 1.4× 150 0.6× 409 2.9× 56 0.6× 114 1.6× 38 1.0k
Stefan Unterecker Germany 14 372 1.3× 235 0.9× 93 0.7× 64 0.7× 116 1.6× 71 818
Ádám Nagy Hungary 14 350 1.3× 495 1.8× 59 0.4× 187 2.0× 28 0.4× 40 1.1k
Denise Sorisio United States 11 182 0.7× 164 0.6× 51 0.4× 73 0.8× 36 0.5× 18 674
F. Bengtsson Sweden 14 141 0.5× 121 0.4× 57 0.4× 174 1.8× 62 0.9× 30 600
I Degrell Hungary 15 221 0.8× 71 0.3× 61 0.4× 79 0.8× 42 0.6× 36 734
Hanako Furukori Japan 20 542 2.0× 114 0.4× 250 1.7× 65 0.7× 136 1.9× 53 1.0k
Barry D. Zussman United Kingdom 15 253 0.9× 344 1.3× 218 1.5× 138 1.5× 86 1.2× 20 915
Christine J. Guico‐Pabia United States 21 263 0.9× 625 2.3× 181 1.3× 104 1.1× 73 1.0× 42 1.1k
George M. Haig United States 16 571 2.1× 448 1.7× 35 0.2× 92 1.0× 137 1.9× 31 1.2k

Countries citing papers authored by Jöns Lundmark

Since Specialization
Citations

This map shows the geographic impact of Jöns Lundmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jöns Lundmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jöns Lundmark more than expected).

Fields of papers citing papers by Jöns Lundmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jöns Lundmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jöns Lundmark. The network helps show where Jöns Lundmark may publish in the future.

Co-authorship network of co-authors of Jöns Lundmark

This figure shows the co-authorship network connecting the top 25 collaborators of Jöns Lundmark. A scholar is included among the top collaborators of Jöns Lundmark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jöns Lundmark. Jöns Lundmark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Murray, Veronica, Magnus von Arbin, Aniko Bartfai, et al.. (2005). Double-Blind Comparison of Sertraline and Placebo in Stroke Patients With Minor Depression and Less Severe Major Depression. The Journal of Clinical Psychiatry. 66(6). 708–716. 84 indexed citations
2.
Reis, Margareta, Jöns Lundmark, & Finn Bengtsson. (2003). Therapeutic Drug Monitoring of Racemic Citalopram: A 5-Year Experience in Sweden, 1992–1997. Therapeutic Drug Monitoring. 25(2). 183–191. 45 indexed citations
3.
Reis, Margareta, Gunilla Olsson, Björn Carlsson, et al.. (2002). Serum Levels of Citalopram and Its Main Metabolites in Adolescent Patients Treated in a Naturalistic Clinical Setting. Journal of Clinical Psychopharmacology. 22(4). 406–413. 16 indexed citations
4.
Skogh, Elisabeth, Margareta Reis, Marja­‐Liisa Dahl, Jöns Lundmark, & Finn Bengtsson. (2002). Therapeutic Drug Monitoring Data on Olanzapine and Its N-Demethyl Metabolite in the Naturalistic Clinical Setting. Therapeutic Drug Monitoring. 24(4). 518–526. 95 indexed citations
5.
Reis, Margareta, Jöns Lundmark, Henrik Björk, & Finn Bengtsson. (2002). Therapeutic Drug Monitoring of Racemic Venlafaxine and Its Main Metabolites in an Everyday Clinical Setting. Therapeutic Drug Monitoring. 24(4). 545–553. 56 indexed citations
6.
Lundmark, Jöns, Margareta Reis, & Finn Bengtsson. (2001). Serum Concentrations of Fluoxetine in the Clinical Treatment Setting. Therapeutic Drug Monitoring. 23(2). 139–147. 49 indexed citations
7.
Carlsson, Björn, Gunilla Olsson, Margareta Reis, et al.. (2001). Enantioselective Analysis of Citalopram and Metabolites in Adolescents. Therapeutic Drug Monitoring. 23(6). 658–664. 41 indexed citations
8.
Lundmark, Jöns, Margareta Reis, & Finn Bengtsson. (2000). Therapeutic Drug Monitoring of Sertraline: Variability Factors as Displayed in a Clinical Setting. Therapeutic Drug Monitoring. 22(4). 446–454. 48 indexed citations
9.
Lundmark, Jöns, F. Bengtsson, Conny Nordin, Margareta Reis, & Jan Wålinder. (2000). Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatrica Scandinavica. 101(5). 354–359. 81 indexed citations
10.
Lundmark, Jöns. (1999). Depression hos äldre.. 2. 29–30.
11.
Bengtsson, Finn, Jöns Lundmark, Conny Nordin, Margareta Reis, & Jan Wålinder. (1997). 127 TDM OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS TREATING DEPRESSION IN THE ELDERLY REDUCES DRUG DOSES AND COSTS. Therapeutic Drug Monitoring. 19(5). 579–579. 4 indexed citations
12.
Bengtsson, F., Peter Höglund, Jöns Lundmark, Conny Nordin, & Jan Wålinder. (1997). A therapeutic drug monitoring (TDM) routine clearly improves dosing, postmarketing surveillance, and drug safety for SSRIs. Biological Psychiatry. 42(1). 87S–87S. 3 indexed citations
13.
Lundmark, Jöns. (1994). The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. European Neuropsychopharmacology. 4(1). 1–6. 18 indexed citations
14.
Lundmark, Jöns, et al.. (1992). Lateral Patient Position for Unilateral ECT.. PubMed. 8(3). 211–212. 1 indexed citations
15.
Lundmark, Jöns, Jan Wålinder, Christer Alling, & P. M. Manniche. (1992). THE EFFECT OF PAROXETINE ON CSF CONCENTRATIONS OF NEUROTRANSMITTER METABOLITES IN DEPRESSED PATIENTS.. Clinical Neuropharmacology. 15. 322B–322B. 2 indexed citations
16.
Lundmark, Jöns, et al.. (1991). No Crossover Reactions to Citalopram or Paroxetine among Patients Hypersensitive to Zimeldine. The British Journal of Psychiatry. 158(6). 853–855. 5 indexed citations
17.
Lundmark, Jöns, et al.. (1989). Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta Psychiatrica Scandinavica. 80(S350). 76–80. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland Berecz Breakdown of academic impact, for papers by Stefan Unterecker Breakdown of academic impact, for papers by Ádám Nagy Breakdown of academic impact, for papers by Denise Sorisio Breakdown of academic impact, for papers by F. Bengtsson Breakdown of academic impact, for papers by I Degrell Breakdown of academic impact, for papers by Hanako Furukori Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by Christine J. Guico‐Pabia Breakdown of academic impact, for papers by George M. Haig
Rankless by CCL
2026